Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1

Abstract

The mechanisms by which p53 prevents development of cancer are much more complicated than previously thought. Under normal conditions, p53 is involved in cell-cycle arrest, Q1apoptosis, DNA repair, and inhibition of angiogenesis; it also promotes degradation of proteins through transcriptional regulation of certain target genes. Here we report the isolation of a novel transcriptional target of p53, designated p53RFP (p53-inducible RING-finger protein), whose product has E3 ubiquitin ligase activity. Its expression was negatively correlated to that of p21WAF1 protein; p53RFP is likely to play a role in the regulation of this protein, probably through interaction with, and ubiquitination of, p21WAF1. p53RFP appears to represent the second known example, the first being MDM2, of an E3 ubiquitin ligase as a p53 target. Our results further suggest that p53 might regulate the stability of p21WAF1 through transcriptional regulation of p53RFP, and this feature may represent a novel mechanism for a p53-dependent cell-cycle checkpoint.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bordallo J, Plemper RK, Finger A and Wolf DH . (1998). Mol. Biol. Cell., 9, 209–222.

  • Blagosklonny MV, Wu GS, Omura S and el-Deiry WS . (1996). Biochem. Biophys. Res. Commun., 227, 564–569.

  • Cayrol C and Ducommun B . (1998). Oncogene, 17, 2437–2444

  • el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B . (1992). Nat. Genet., 1, 45–49

  • Fang S, Jensen JP, Ludwig RL, Vousden KH and Weissman AM . (2000). J. Biol. Chem., 275, 8945–8951

  • Fukuchi K, Maruyama H, Takagi Y and Gomi K . (1999). Biochim. Biophys. Acta, 1451, 206–210

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ . (1993). Cell, 75, 805–816

  • Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC . (1994). Nucleic Acids Res., 22, 3551–3555

  • Hupp TR, Lane DP and Ball KL . (2000). Biochem. J., 352(Part 1), 1–17

  • Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, Kaiser BK and Reimann JD . (2000). Trends Cell. Biol., 10, 429–439

  • Joazeiro CA and Weissman AM . (2000). Cell, 102, 549–552

  • Marin I and Ferrus A . (2002). Mol. Biol. Evol., 19, 2039–2050

  • Matsuda N, Suzuki T, Tanaka K and Nakano A . (2001). J. Cell. Sci., 114, 1949–1957

  • Mimnaugh EG, Bonvini P and Neckers L . (1999). Electrophoresis, 20, 418–428

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y . (2000). Cell, 102, 849–862

  • Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M and Nakamura Y . (2001). Mol. Cell, 8, 85–94

  • Pickart CM . (2001). Mol. Cell, 8, 499–504

  • Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A and Fotedar R . (1999). Oncogene, 18, 4313–4325

  • Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, Nakamura Y and Tokino T . (2002). J. Biol. Chem., 277, 719–724

  • Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM and Clurman BE . (2000). Mol. Cell, 5, 403–410

  • Tokino T and Nakamura Y . (2000). Crit. Rev. Oncol. Hematol., 33, 1–6

  • Touitou R, Richardson J, Bose S, Nakanishi M, Rivett J and Allday MJ . (2001). EMBO J., 20, 2367–2375

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310

  • Yu ZK, Gervais JL and Zhang H . (1998). Proc. Natl. Acad. Sci. USA., 95, 11324–11329

  • Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW and Vogelstein B . (1999). Proc. Natl. Acad. Sci. USA, 96, 14517–14522

  • Zhang Y, Gao J, Chung KK, Huang H, Dawson VL and Dawson TM . (2000). Proc. Natl. Acad. Sci. USA., 97, 13354–13359

  • Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH and Levine AJ . (2000). Genes Dev., 14, 981–993

Download references

Acknowledgements

We thank Dr Bert Vogelstein for HCT116 (p53+/+) and HCT116 (p53−/−) cell line and Dr K Miyazono for the HA-ubiquitin plasmid. We also thank K Matsui and S Onoue for their excellent technical assistance. This work was supported in part by Research for the Future Program Grant 00 L01402 from the Japan Society for the Promotion of Science (to YN), and in part by Grant 13216031 from the Ministry of Education, Culture, Sports, Science and Technology (to HA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusuke Nakamura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, CC., Arakawa, H., Fukuda, S. et al. p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1. Oncogene 22, 4449–4458 (2003). https://doi.org/10.1038/sj.onc.1206586

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206586

Keywords

This article is cited by

Search

Quick links